We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
128 own
24 watching
Current Price
$76.36
$0.45
(0.59%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
47,297.38M
52-Week High
131.73
52-Week Low
67.13
Average Volume
1.57M
Dividend Yield
--
P/E Ratio
50.7353
Market Capitalization47,297.38M
52-Week High131.73
52-Week Low67.13
Average Volume1.57M
Dividend Yield--
P/E Ratio50.7353
What does the Stockal+Disclaimer.pdf do?
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve. In addition, it produces pericardial valves from biologically inert animal tissue; and provides heart valve repair therapies, including annuloplasty rings and systems. Further, the company offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; and Oximetry Central Venous Catheters for continuous measurement of central venous oxygen saturation. Additionally, its critical care products include disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as embolectomy catheters for removing blood clots from peripheral blood vessels. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
13days ago
Summit Trail Advisors LLC bought a new position in Edwards Lifesciences Co. (NYSE:EW Get Rating) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 2,501 shares of the medical research companys stock, valued at approximately $238,...
Zolmax
18days ago
Coldstream Capital Management Inc. decreased its holdings in Edwards Lifesciences Co. (NYSE:EW Get Rating) by 38.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,578 shares of the medical research companys stock after ...
Ticker Report
18days ago
Coldstream Capital Management Inc. decreased its holdings in Edwards Lifesciences Co. (NYSE:EW Get Rating) by 38.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,578 shares of the medical research company&#8217...
Ticker Report
21days ago
Edwards Lifesciences Co. (NYSE:EW Get Rating)s stock price reached a new 52-week low during trading on Thursday after The Goldman Sachs Group lowered their price target on the stock from $97.00 to $73.00. The Goldman Sachs Group currently has a neutral rating on the stock. Edwards ...
Ticker Report
26days ago
Edwards Lifesciences (NYSE:EW Get Rating) had its price target decreased by Morgan Stanley from $108.00 to $98.00 in a report released on Friday morning, Stock Target Advisor reports. Morgan Stanley currently has an overweight rating on the medical research companys stock. Several ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$76.36
$0.45
(0.59%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00